- Report
- August 2021
- 210 Pages
Global
From €5679EUR$5,950USD£4,758GBP
The Ophthalmic Photocoagulator is a medical device used to treat eye diseases such as glaucoma, diabetic retinopathy, and macular degeneration. It uses a laser to seal off leaking blood vessels, reduce intraocular pressure, and destroy abnormal tissue. The device is used to treat a variety of eye conditions, including retinal tears, macular holes, and retinal detachment. It is also used to treat age-related macular degeneration, diabetic retinopathy, and other retinal diseases.
The Ophthalmic Photocoagulator market is a rapidly growing segment of the medical device industry. It is driven by the increasing prevalence of eye diseases, the development of new technologies, and the growing demand for minimally invasive treatments. The market is expected to continue to grow in the coming years, as new treatments and technologies are developed.
Some of the major companies in the Ophthalmic Photocoagulator market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Iridex, Nidek, Optos, Topcon, and Ziemer. Show Less Read more